Market revenue in 2024 | USD 118.3 million |
Market revenue in 2030 | USD 235.5 million |
Growth rate | 12.2% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.42% in 2024. Horizon Databook has segmented the Japan pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The competitive scenario of the pancreatic cancer treatment market in Japan is driven by a strong focus on innovation and strategic partnerships, positioning the country as a critical market for global pharmaceutical companies such as AstraZeneca, Novartis AG, and Bristol-Myers Squibb Company.
reflecting its prominence as a hub for research and development. Novartis AG’s targeted therapies, supported by Japan’s widespread use of next-generation sequencing technologies, are gaining traction, further intensifying competition.
Japan’s pancreatic cancer treatment landscape is influenced by its demographic and healthcare spending dynamics. According to WHO, in 2022, Japan recorded 47,627 new cases of pancreatic cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Japan pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account